A new study examines whether endocrine-disrupting chemicals, common chemicals found in plastics, personal care products, and some general household items, are related to early-onset menopause.
The US Food and Drug Administration has approved the stimulant lisdexamfetamine to treat binge-eating disorder, the first product to be approved for the condition.
Researchers have discovered a mechanism that leads to the degradation of upper motor neurons, cells linked to the development of amyotrophic lateral sclerosis.
New research explored the option of treating ACE inhibitor–induced angioedema, a potentially life-threatening condition, with the bradykinin BB2-receptor antagonist icatibant.